Detalhe da pesquisa
1.
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines.
Pharmacol Rev
; 74(1): 313-339, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101964
2.
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.
N Engl J Med
; 382(4): 318-327, 2020 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971677
3.
B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis.
J Infect Dis
; 225(4): 637-649, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487174
4.
A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model.
BMC Infect Dis
; 21(1): 1244, 2021 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895161
5.
Challenges in synthesis of real-world vaccine effects on meningococcal serogroup B disease for 4CMenB vaccine post-licensure effectiveness studies: A systematic review.
Vaccine
; 41(30): 4347-4358, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321895
6.
Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB.
J Infect
; 85(5): 481-491, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087745
7.
Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines.
mSphere
; 7(5): e0038522, 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129279
8.
Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B.
NPJ Vaccines
; 6(1): 29, 2021 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33623041
9.
Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect.
NPJ Vaccines
; 6(1): 130, 2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716336
10.
Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England.
Vaccine
; 38(47): 7558-7568, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32807531
11.
B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis.
BMJ Open
; 9(5): e027233, 2019 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31064808
12.
Meningococcal B vaccine (4CMenB): the journey from research to real world experience.
Expert Rev Vaccines
; 17(12): 1111-1121, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30457407
13.
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents.
BMJ Open
; 8(7): e020988, 2018 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991629